Tilray
-$0.16 (-0.80%) Today
-$0.02 (-0.10%) As of 12:00 AM UTC after-hours
Why Robinhood?
You can buy or sell Tilray and other stocks, options, and ETFs commission-free!
About TLRY
Tilray, Inc. engages in the research, cultivation, production, and distribution of medical cannabis and cannabinoids. The Company is focused on medical cannabis research, cultivation, processing and distribution of cannabis products worldwide.
CEO
Irwin David Simon
Employees
1,030
Headquarters
Nanaimo, British Columbia
Founded
2018
TLRY Key Statistics
Market Cap
8.95B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
46.44M
High Today
$20.20
Low Today
$19.36
Open Price
$19.89
Volume
22.58M
52 Week High
$67.00
52 Week Low
$4.41
TLRY News
BenzingaJun 9
EXCLUSIVE: Tilray CEO Talks Symbios, Aphria, Market Opportunities On 'Power Hour'
Tilray Inc (NASDAQ:TLRY) recently announced the launch of Symbios, a medical cannabis brand the cannabis company said will provide a broader spectrum of formats
Analyst Ratings
57%
of 14 ratings
Buy
35.7%
Hold
57.1%
Sell
7.1%
TLRY Earnings
-$1.75
-$1.17
-$0.58
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Aug 9, Pre-Market
